DennisLCarterMD

Radiation Oncology • Aurora, CO

Physician

Join to view full profile

Dr. Carter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Carter's full profile

Already have an account?

Office
1700 S Potomac St
Aurora, CO 80012
Phone+1 303-418-7600

Fax+1 303-750-3137

Education & Training

Duke University HospitalResidency, Radiation Oncology, 1994 - 1998
Deaconess Medical Center (Spokane)Internship, Transitional Year, 1993 - 1994
University of Washington School of MedicineClass of 1993

Certifications & Licensure

CO State Medical License 2001 - 2025
NC State Medical License 1994 - 1998

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2013-2014

Clinical Trials

FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma Start of enrollment: 2008 Jul 01
Withdrawn
Phase 2, Phase 3
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy Start of enrollment: 2009 Jul 01
Recruiting
Phase 3
Accelerated Partial Breast Radiotherapy With Either Mammosite or Intensity Modulated Radiotherapy Start of enrollment: 2004 Feb 01
Active, not recruiting
Phase 2
Definitive Therapy for Oligometastatic Solid Malignancies Start of enrollment: 2005 Dec 01
Unknown status
Phase 2
Join now to see all

Publications & Presentations

PubMed

313 citations
An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer
A. Ashworth, Suresh Senan, David A. Palma, Marc Riquet, Yong Chan Ahn
Clinical Lung Cancer. 2014-09-01
271 citations
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients
Andrew S. Kennedy, William A. Dezarn, Patrick McNeillie, Doug Coldwell, Charles W. Nutting
American Journal of Clinical Oncology. 2008-06-01
32 citations
The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 1...
Michael Alvarado, Dennis L. Carter, J. Michael Guenther, James Hagans, Rachel Y. Lei
Journal of Surgical Oncology. 2015-06-01